top of page

Interview with CCTV on Personalized Cancer Treatment

  • Writer: Dr. Robert A. Nagourney, MD
    Dr. Robert A. Nagourney, MD
  • Apr 3, 2015
  • 1 min read

Updated: Oct 24, 2021

This Saturday, April 4, my interview on CCTV's program FULL FRAME will be aired. The Mike Walters interview focuses on my study of human cancer using the 3-D microspheroid EVA-PCD platform. We review the excellent patient outcomes associated with the use of this technology to select chemotherapy drugs and targeted agents.

The program streams live online Sat. at 4 p.m. http://www.cctv-america.com/livenews

The program is already available on the CCTV menu of videos at: http://www.cctv-america.com/videos Scroll down the list of available programming until you see Cancer Treatments: One size does not fit all.

CCTV is an international network with millions of viewers. The program, Full Frame, is a news magazine format that conducts in-depth interviews involving current topics of interest.

Comments


Nagourney Cancer Institute
  • Facebook
  • YouTube
  • Instagram

Nagourney Cancer Institute is managed by Rational Therapeutics, LLC. 

EVA-PCD, Target Rx, and Translational Rx are registered trademarks of Rational Therapeutics.

Nagourney Cancer Institute.  750 E. 29th Street, Long Beach, CA 90806   (800) 542-4357   All rights reserved. 

bottom of page